Literature DB >> 29417259

Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply.

Zhigang Yang1, Hong Yao2, Fei Fei3,4, Yuwei Li5, Jie Qu3,4, Chunyuan Li3,4, Shiwu Zhang6.   

Abstract

INTRODUCTION: During development and tumor progression, cells need a sufficient blood supply to maintain development and rapid growth. It is reported that there are three patterns of blood supply for tumor growth: endothelium-dependent vessels, mosaic vessels, and vasculogenic mimicry (VM). VM was first reported in highly aggressive uveal melanomas, with tumor cells mimicking the presence and function of endothelial cells forming the walls of VM vessels. The walls of mosaic vessels are randomly lined with both endothelial cells and tumor cells. We previously proposed a three-stage process, beginning with VM, progressing to mosaic vessels, and eventually leading to endothelium-dependent vessels. However, many phenomena unique to VM channel formation remain to be elucidated, such as the origin of erythrocytes before VM vessels connect with endothelium-dependent vessels.
RESULTS: In adults, erythroid cells are generally believed to be generated from hematopoietic stem cells in the bone marrow. In contrast, embryonic tissue obtains oxygen through formation of blood islands, which are largely composed of embryonic hemoglobin with a higher affinity with oxygen, in the absence of mature erythrocytes. Recent data from our laboratory suggest that embryonic blood-forming mechanisms also exist in cancer tissue, particularly when these tissues are under environmental stress such as hypoxia. We review the evidence from induced pluripotent stem cells in vitro and in vivo to support this previously underappreciated cell functionality in normal and cancer cells, including the ability to generate erythroid cells. We will also summarize the current understanding of tumor angiogenesis, VM, and our recent work on polyploid giant cancer cells, with emphasis on their ability to generate erythroid cells and their association with tumor growth under hypoxia.
CONCLUSION: An alternative embryonic pathway to obtain oxygen in cancer cells exists, particularly when they are under hypoxic conditions.

Entities:  

Keywords:  Cancer stem cells; Erythropoiesis; Polyploidy giant cancer cells; Vasculogenic mimicry

Mesh:

Year:  2018        PMID: 29417259     DOI: 10.1007/s00432-018-2598-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  102 in total

1.  Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).

Authors:  Jakub Tolar; In-Hyun Park; Lily Xia; Chris J Lees; Brandon Peacock; Beau Webber; Ron T McElmurry; Cindy R Eide; Paul J Orchard; Michael Kyba; Mark J Osborn; Troy C Lund; John E Wagner; George Q Daley; Bruce R Blazar
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

2.  Creating a new structure for research on health care effectiveness.

Authors:  Joel Kupersmith; Nancy Sung; Myron Genel; Harold Slavkin; Robert Califf; Robert Bonow; Louis Sherwood; Nancy Reame; Veronica Catanese; Catherine Baase; John Feussner; Adrian Dobs; Hugh Tilson; E Albert Reece
Journal:  J Investig Med       Date:  2005-03       Impact factor: 2.895

Review 3.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

Review 4.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

5.  Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.

Authors:  Ou-Yang Fu; Ming-Feng Hou; Sheau-Fang Yang; Soon-Cen Huang; Wen-Ying Lee
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

Review 6.  Embryonic origin of the adult hematopoietic system: advances and questions.

Authors:  Alexander Medvinsky; Stanislav Rybtsov; Samir Taoudi
Journal:  Development       Date:  2011-03       Impact factor: 6.868

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.

Authors:  Baocun Sun; Shuo Qie; Shiwu Zhang; Tao Sun; Xiulan Zhao; Songyuan Gao; Chunsheng Ni; Xinghui Wang; Yanxue Liu; Lihua Zhang
Journal:  Hum Pathol       Date:  2008-03       Impact factor: 3.466

Review 9.  Cancer stem cells: a model in the making.

Authors:  Lauren L Campbell Marotta; Kornelia Polyak
Journal:  Curr Opin Genet Dev       Date:  2009-01-21       Impact factor: 5.578

10.  Molecular determinants of human uveal melanoma invasion and metastasis.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M Trent; Robert Folberg; Mary J C Hendrix
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  15 in total

Review 1.  Giants and monsters: Unexpected characters in the story of cancer recurrence.

Authors:  Shai White-Gilbertson; Christina Voelkel-Johnson
Journal:  Adv Cancer Res       Date:  2020-05-04       Impact factor: 6.242

Review 2.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

3.  Immunohistochemistry for VM Markers.

Authors:  Alessio Biagioni; Elena Andreucci
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance.

Authors:  Sarah R Amend; Gonzalo Torga; Ke-Chih Lin; Laurie G Kostecka; Angelo de Marzo; Robert H Austin; Kenneth J Pienta
Journal:  Prostate       Date:  2019-08-02       Impact factor: 4.104

Review 5.  Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors.

Authors:  Christina Voelkel-Johnson
Journal:  Semin Cancer Biol       Date:  2021-01-08       Impact factor: 17.012

Review 6.  Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments.

Authors:  Ghmkin Hassan; Masaharu Seno
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

Review 7.  Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.

Authors:  Xue Zhang; Jigang Zhang; Heming Zhou; Guorong Fan; Qin Li
Journal:  J Cancer       Date:  2019-10-18       Impact factor: 4.207

Review 8.  Role of cancer stem cells in the development of giant cell tumor of bone.

Authors:  Abdul Rouf War; Kai Dang; Shanfen Jiang; Zhongwei Xiao; Zhiping Miao; Tuanmin Yang; Yu Li; Airong Qian
Journal:  Cancer Cell Int       Date:  2020-04-25       Impact factor: 5.722

Review 9.  Endothelial cells in colorectal cancer.

Authors:  Wu-Zhen Chen; Jing-Xin Jiang; Xiu-Yan Yu; Wen-Jie Xia; Peng-Xin Yu; Ke Wang; Zhi-Yong Zhao; Zhi-Gang Chen
Journal:  World J Gastrointest Oncol       Date:  2019-11-15

10.  Molecular Mechanisms by Which S100A4 Regulates the Migration and Invasion of PGCCs With Their Daughter Cells in Human Colorectal Cancer.

Authors:  Fei Fei; Kai Liu; Chunyuan Li; Jiaxing Du; Zhen Wei; Bo Li; Yuwei Li; Yi Zhang; Shiwu Zhang
Journal:  Front Oncol       Date:  2020-02-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.